AMLX
NASDAQ · Pharmaceuticals
Amylyx Pharmaceuticals Inc
$29.50
+1.88 (+6.81%)
Open$27.73
Previous Close$27.62
Day High$29.58
Day Low$27.50
52W High$41.14
52W Low$10.83
Volume—
Avg Volume1.28M
Market Cap3.70B
P/E Ratio—
EPS$-1.43
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
+25.9% upside
Current
$29.50
$29.50
Target
$37.15
$37.15
$28.49
$37.15 avg
$49.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 140.51M | 449.35M | 403.13M |
| Net Income | -485,264,659 | 64.17M | 62.78M |
| Profit Margin | -345.4% | 14.3% | 15.6% |
| EBITDA | -506,644,708 | 107.91M | 96.37M |
| Free Cash Flow | — | 81.20M | 53.03M |
| Rev Growth | +574.3% | +13.9% | +9.9% |
| Debt/Equity | — | 0.29 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |